The vaccine has been available under an emergency use authorisation (EUA) to people as young as 16 in the United States. It is the first Covid-19 vaccine to be authorised in the United States for this age group, seen as an important step for getting children back into schools safely. But many health officials are concerned vaccine hesitancy in some adults will be even more pronounced when it comes to their children. Pfizer and BioNTech asked the FDA to expand their EUA to include the younger age group in early April. Pfizer's vaccine is the only one authorised for 16 and 17 year olds in the United States.

Source: Otago Daily Times May 10, 2021 23:26 UTC